The Global Single-use Bioreactors Market valued at ~$3.39 billion (2021) is set to witness a healthy growth rate of 20% in the next 5 years. The introduction of large-scale single-use bioreactors, rising demand from pharma companies, CROs, and CDMOs, the expanding biologics market, rising biopharmaceutical R&D, and the advantages of single-use bioreactors are some of the technological advancements that are propelling the global single-use bioreactors market.